Familial hematological malignancies: new IDH2 mutation.

about

GATA2 gene analysis in several forms of hematological malignancies including familial aggregations.

P2860

Q46394161-0563AF52-AF62-4069-8883-63A9D8976ADF

P2860

Familial hematological malignancies: new IDH2 mutation.

Item

http://www.wikidata.org/entity/Q46677889

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Familial hematological malignancies: new IDH2 mutation.

@en

Familial hematological malignancies: new IDH2 mutation.

@nl

type

Item

label

Familial hematological malignancies: new IDH2 mutation.

@en

Familial hematological malignancies: new IDH2 mutation.

@nl

prefLabel

Familial hematological malignancies: new IDH2 mutation.

@en

Familial hematological malignancies: new IDH2 mutation.

@nl

P1476

Familial hematological malignancies: new IDH2 mutation

@en

P2093

Abderrahim Khélif

http://www.w3.org/2001/XMLSchema#string

Catherine Dugast

http://www.w3.org/2001/XMLSchema#string

Chaker Ben Salem

http://www.w3.org/2001/XMLSchema#string

Fabienne Brenet

http://www.w3.org/2001/XMLSchema#string

Hagay Sobol

http://www.w3.org/2001/XMLSchema#string

Hélène Dreyfus

http://www.w3.org/2001/XMLSchema#string

Hélène Zattara

http://www.w3.org/2001/XMLSchema#string

Laurence Faivre

http://www.w3.org/2001/XMLSchema#string

Mohamed-Adnène Laatiri

http://www.w3.org/2001/XMLSchema#string

Paul Gesta

http://www.w3.org/2001/XMLSchema#string

P2860

The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate

An integrated genomic analysis of human glioblastoma multiforme

Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor.

Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia: prevalence and prognostic value.

Suppressor of cytokine signaling 6 associates with KIT and regulates KIT receptor signaling

Alterations of metabolic genes and metabolites in cancer.

Cancer-associated IDH mutations: biomarker and therapeutic opportunities.

The emerging role of d-2-hydroxyglutarate as an oncometabolite in hematolymphoid and central nervous system neoplasms.

Insights into RNA structure and function from genome-wide studies.

Photoactivation of Mutant Isocitrate Dehydrogenase 2 Reveals Rapid Cancer-Associated Metabolic and Epigenetic Changes.

P304

1943-1947

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00277-016-2813-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Patrice Dubreuil

F Eisinger

Angelo Paci

Virginie Penard-Lacronique

Muriel D David

P577

2016-09-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27591990

http://www.w3.org/2001/XMLSchema#string

Familial hematological malignancies: new IDH2 mutation.

about

P2860

P2860

Familial hematological malignancies: new IDH2 mutation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698